Plakoglobin (c-catenin) is a homolog of b-catenin with similar dual adhesive and signaling functions. The adhesive function of these proteins is mediated by their interactions with cadherins, whereas their signaling activity is regulated by association with various intracellular partners. In this respect, b-catenin has a well-defined oncogenic activity through its role in the Wnt signaling pathway, whereas plakoglobin acts as a tumor/metastasis suppressor through mechanisms that remain unclear. We previously expressed plakoglobin in SCC9 squamous carcinoma cells (SCC9-P) and observed a mesenchymalto-epidermoid transition. Comparison of the protein and RNA profiles of parental SCC9 cells and SCC9-P transfectants identified various differentially expressed proteins and transcripts, including the nonmetastatic protein 23 (Nm23). In this study, we show that Nm23-H1 mRNA and Nm23-H2 protein are increased after plakoglobin expression. Coimmunoprecipitation and confocal microscopy studies using SCC9-P and various epithelial cell lines with endogenous plakoglobin expression revealed that Nm23 interacts with plakoglobin, cadherins and a-catenin. Furthermore, Nm23-H2 is the primary isoform involved in these interactions, which occur prominently in the cytoskeleton-associated pool of cellular proteins. In addition, we show that plakoglobinNm23 interaction requires the N-terminal (a-catenin interacting) domain of plakoglobin. Our data suggest that by increasing the expression and stability of Nm23, plakoglobin has a role in regulating the metastasis suppressor activity of Nm23, which may further provide a potential mechanism for the tumor/metastasis suppressor function of plakoglobin itself.
Introduction
In epithelia, adhesive intercellular junctional complexes, namely, the adherens junctions and desmosomes, function to connect neighboring cells to one another, as well as limit proliferation and migration, regulate tissue morphogenesis and maintain tissue integrity (Green and Simpson, 2007; Holthofer et al., 2007; Garrod and Chidgey, 2008; Garrod and Kimura, 2008; Hartsock and Nelson, 2008; Niessen and Gottardi, 2008) . Cadherins are calcium-dependent transmembrane glycoproteins that mediate homotypic cell-cell interactions. Although the extracellular domain of cadherins interacts with cadherin molecules on adjacent cells, the intracellular domain interacts in a mutually exclusive manner, with either b-catenin or plakoglobin (g-catenin), which then interacts with a-catenin. a-Catenin, which binds actin, tethers the cadherin-catenin complex to the actin cytoskeleton (Perez-Moreno and Fuchs, 2006; Benjamin and Nelson, 2008; Nelson, 2008; Stemmler, 2008; van Roy and Berx, 2008) .
b-catenin and plakoglobin are members of the Armadillo family of proteins and are structural homologs (Peifer et al., 1992) . Both interact with E-cadherin, a-catenin, Axin and APC and both have been shown to be involved in Wnt signaling (Ben-Ze'ev and Geiger, 1998; Zhurinsky et al., 2000b; Chidgey and Dawson, 2007) . In addition to its associations with classic cadherins, plakoglobin interacts with desmosomal cadherins and is essential for the formation of desmosomes (Parker et al., 1998; Holthofer et al., 2007; Garrod and Chidgey, 2008) , whereas b-catenin typically does not. Furthermore, although both b-catenin and plakoglobin can interact with the Tcf/Lef family of transcription factors, only the b-catenin-Tcf complexes have transcriptional activity, whereas the plakoglobin-Tcf complex is unable to bind DNA (Simcha et al., 1998; Zhurinsky et al., 2000a) .
b-catenin's oncogenic potential is well documented, and mutations resulting in its stabilization and nuclear accumulation have been observed in various carcinomas (Gavert and Ben-Ze'ev, 2007; Huang and He, 2008; Huber and Weiske, 2008; Jeanes et al., 2008; Jin et al., 2008) . In contrast, plakoglobin has typically been associated with tumor/metastasis-suppressor activity, although the mechanism behind this activity is not understood (Simcha et al., 1996; Pantel et al., 1998; Parker et al., 1998; Winn et al., 2002; Reiger-Christ et al., 2005; Kanazawa et al., 2008) .
Nonmetastatic protein 23 (Nm23) is a nucleoside diphosphate kinase that is expressed from bacteria to mammals (Tee et al., 2006) . In humans, there are eight members of the Nm23 family (Nm23-H1-8, respectively), and in addition to their nucleoside diphosphate kinase activity, members of this family have both histidine protein kinase and phosphotransferase activities (Wagner et al., 1997; Lacombe et al., 2000; Steeg et al., 2008) . Nm23-H1, which has DNase activity (Fan et al., 2003) , is primarily cytoplasmic, whereas Nm23-H2 is both nuclear and cytoplasmic, and binds DNA (Postel et al., 2000; Bosnar et al., 2004 Bosnar et al., , 2009 ). Identified as the first metastasis suppressor, decreased expression of Nm23-H1 is associated with higher tumor grade and increased metastasis (MacDonald et al., 1993; Steeg et al., 1998 Steeg et al., , 2003 . Exogenous expression of Nm23-H1 results in decreased migration in vitro and metastasis in vivo. In addition to decreased migration, overexpression of Nm23-H1 leads to increased cell adhesion, the inhibition of anchorageindependent growth and the induction of cellular differentiation (Lee and Lee, 1999; Khan et al., 2001; Suzuki et al., 2004; Jung et al., 2006; McDermott et al., 2008; Bago et al., 2009) .
We previously showed that exogenous expression of plakoglobin in SCC9 cells, a human tongue squamous cell carcinoma cell line that lacks endogenous plakoglobin and E-cadherin expression, induced desmosome formation and stabilized N-cadherin, concurrent with the appearance of an epidermoid phenotype (Parker et al., 1998) . In an attempt to identify the mechanism(s) underlying this phenotypic transition, we compared the proteomic profiles of SCC9-P and parental SCC9 cells, as previously described for E-cadherin-expressing SCC9 cells (M Pasdar, unpublished; Ji et al., 2005) . We identified several tumorsuppressor proteins that showed significantly higher levels in SCC9-P cells, including Nm23, the increased expression of which was also detected by microarrays comparing the RNA profiles of SCC9 and SCC9-P cells (Z Aktary, unpublished) In this study, we investigated the effect of plakoglobin expression on Nm23 levels and localization. Our results show that plakoglobin expression leads to the induction of Nm23-H1 mRNA and increased the protein level of both Nm23-H1 and H2. On plakoglobin expression, Nm23 interacts not only with plakoglobin but also with N-cadherin and a-catenin, and these interactions occur at the sites of cell-cell contacts. We further confirmed these results in a number of nonepidermal epithelial cell lines. Our results suggest that plakoglobin may assert part of its tumor-suppressive activity through modulating the expression and subcellular localization of the metastasis suppressor Nm23, and that a-catenin acts as a bridge between plakoglobin and Nm23.
Results
Increased Nm23 levels and its membrane localization in SCC9-P cells Plakoglobin expression in SCC9 cells (SCC9-P) induces a mesenchymal-to-epidermoid phenotypic transition (Parker et al., 1998) . To identify the underlying molecular mechanism for this phenotypic conversion, we examined the protein and RNA profiles of SCC9 and SCC9-P cells. Various tumor suppressors were identified as being increased on plakoglobin expression, and among them was Nm23-H2 (M Pasdar and Z Aktary, unpublished) . Figure 1 shows that, on plakoglobin expression, the levels of both Nm23-H1 and H2 protein were increased, although the levels of Nm23-H2 were markedly higher than those of Nm23-H1 (Figure 1a) , which was in agreement with our proteomics results in which Nm23-H2 levels were increased nearly fivefold in SCC9-P cells. To examine plakoglobin's effect on Nm23 expression, we performed reverse-transcription experiments. Our data show that although the levels of Nm23-H1 mRNA were increased in SCC9-P cells, the levels of Nm23-H2 mRNA were unaltered (Figure 1b ), in agreement with our microarray data, which also revealed a twofold increase in the level of Nm23-H1 mRNA, whereas H2 levels remained unchanged (Z Aktary, unpublished). Figure 1c revealed that not only are Nm23 protein levels increased in SCC9-P cells but also some of it seemed to be localized to the cell-cell contact areas. This raised the question of whether the membrane-localized Nm23 is associated with cell-cell junctions. To address this possibility, soluble and insoluble (cytoskeleton associated) fractions from SCC9 and SCC9-P cell extracts Figure 1 Plakoglobin expression results in increased Nm23 protein and mRNA levels and its localization to the areas of cell-cell contact. (a) Equal amounts of total cellular proteins from SCC9 and SCC9-P cells were resolved by SDS-PAGE and processed for immunoblotting with antibodies to Nm23 and tubulin. (b) Total cellular RNA was isolated from SCC9 and SCC9-P cells, reverse transcribed and processed for PCR using primers specific to Nm23-H1, -H2 and GADPH. (c) SCC9 and SCC9-P cells were grown on glass coverslips, methanol-acetone fixed and processed for confocal microscopy with Nm23 antibodies (red). Nuclei were stained with DAPI (blue). Bar, 20 mm. A full colour version of this figure is available at the Oncogene journal online.
Nm23 coprecipitates with plakoglobin and N-cadherin
Plakoglobin interacts with and regulates Nm23 Z Aktary et al were processed for immunoprecipitation with plakoglobin or N-cadherin antibodies, followed by immunoblotting with Nm23 antibodies. Plakoglobin antibodies coprecipitated only Nm23-H2 from the soluble fraction, and both Nm23-H1 and H2 from the insoluble fraction of SCC9-P cells, although the amount of Nm23-H2 coprecipitated was notably higher than that of H1 ( Figure 2a , IP: plakoglobin). As expected, immunoprecipitation of plakoglobin yielded negative results for association with Nm23 in SCC9 cells. In SCC9 cells, N-cadherin antibodies coprecipitated very small amounts of Nm23-H1 and H2, mostly in the insoluble fraction. In SCC9-P cells, plakoglobin expression increased the amount of Nm23 coprecipitated with N-cadherin ( Figure 2a , IP: N-cadherin). As with plakoglobin, more amounts of Nm23-H2 than H1 were coprecipitated with N-cadherin antibodies. Nm23 associations with plakoglobin and N-cadherin were further confirmed by reciprocal immunoprecipitations, in which cell extracts were immunoprecipitated with Nm23 antibodies and blotted for plakoglobin and N-cadherin ( Figure 3b ).
Nm23 colocalizes at the membrane with plakoglobin and N-cadherin
We further confirmed the results of our coimmunoprecipitation studies with confocal microscopy using Nm23-H1/H2, plakoglobin and N-cadherin antibodies in conjunction with two different extraction/fixation protocols. To visualize the entire cellular pool of proteins, cells were first fixed using formaldehyde and subsequently permeabilized using CSK extraction buffer. Alternatively, CSK extraction buffer was used first to permeabilize and extract the soluble pool of cellular proteins, followed by fixation with formaldehyde, allowing for the visualization of the cytoskeletonassociated pool of proteins (Pasdar and Nelson, 1988b; Pasdar et al., 1995) , including those stabilized by association with the adhesive complexes.
Staining of fixed/permeabilized SCC9 cells with N-cadherin and Nm23-H1/H2 antibodies showed that Nm23 was distributed throughout the cell, whereas N-cadherin was primarily detected at the membrane ( When SCC9 cells were extracted before fixation, most of the staining for both Nm23-H1/H2 and N-cadherin observed in fixed/permeabilized cells was removed ( Figure 2c and Supplementary Figure 1 ). Under these conditions, SCC9-P cells showed colocalization between Nm23-H1/H2 and N-cadherin, as well as Nm23-H1/H2 and plakoglobin; furthermore, these codistributions Figure 2 Nm23 interacts with plakoglobin and N-cadherin in SCC9-P cells. (a) Soluble and insoluble fractions from SCC9 and SCC9-P cell extracts were processed for immunoprecipitation using N-cadherin, plakoglobin and control antibodies. Immune complexes were resolved by SDS-PAGE and immunoblotted with antibodies to Nm23. (b) SCC9 and SCC9-P cells were formaldehyde fixed, CSK buffer extracted and stained with Nm23 (red) and N-cadherin or plakoglobin (green) antibodies to visualize the total distribution of proteins. Nuclei were counterstained with DAPI (blue). Bar, 20 mm. (c) To visualize the cytoskeleton-associated (insoluble) proteins, cells were first extracted with CSK buffer and then fixed using formaldehyde before they were processed for confocal microscopy as described in b. Bar, 20 mm. A full colour version of this figure is available at the Oncogene journal online.
Plakoglobin interacts with and regulates Nm23
Z Aktary et al were primarily at the membrane ( Figure 2c , SCC9-P). Thus, Nm23 colocalizes with the cytoskeleton-associated pool of plakoglobin and N-cadherin.
Nm23 interacts with a-catenin
Increased levels of Nm23-H1 and H2 associated with the insoluble N-cadherin in SCC9-P cells and its membrane codistribution with both plakoglobin and N-cadherin in these cells suggested that plakoglobin expression may have led to the association of Nm23 with the stable cadherin-catenin complexes at the adherens junction.
To this end, we examined whether a-catenin, which mediates N-cadherin-plakoglobin interactions with the actin cytoskeleton, may also associate with Nm23-H1 and H2. Figure 3a shows that in SCC9 cells, only Nm23-H2 is associated with a-catenin, mainly in the insoluble fraction ( Figure 3a , SCC9). In contrast, in SCC9P cells, a-catenin antibodies coprecipitated Nm23-H2 and to a lesser extent H1 from both soluble and insoluble fractions ( Figure 3a , SCC9-P). Reciprocal coimmunoprecipitation with Nm23 antibodies also detected a-catenin in the insoluble fraction of both SCC9 and SCC9-P cells, with significantly higher levels in the latter ( Figure 3b ). These observations were further verified by immunofluorescence assays, which clearly showed a-catenin codistribution with Nm23-H1/H2 in SCC9-P cells, whereas this colocalization was barely detectable in SCC9 cells ( Figure 3c ). Collectively, these results suggest that plakoglobin expression stabilizes Nm23-H1
and H2 interactions with cadherin-catenin complexes at the membrane.
The N-terminal domain of plakoglobin is necessary for interaction with Nm23 So far, our data suggest that Nm23-H1 and H2, plakoglobin, a-catenin and N-cadherin may be present in the same complex. We then asked whether a-catenin could be a bridge between Nm23 and plakoglobin-Ncadherin complexes. To clarify this point, we assessed the interactions between Nm23, plakoglobin and Ncadherin in SCC9 cells expressing Flag-tagged wild-type plakoglobin or a mutant plakoglobin with a deletion in the N-terminal a-catenin binding domain (Pg-DN123; Li et al., 2007; Kolligs et al., 2000) . Soluble and insoluble cell extracts from Pg-Flag and Pg-DN123 transfectants were processed for sequential immunoprecipitation and immunoblotting with Flag and Nm23 antibodies, respectively. Plakoglobin coprecipitated Nm23-H2 from the insoluble fractions of Pg-Flag cells but not from those of Pg-DN123 cells in which plakoglobin is unable to bind a-catenin (Figure 4a, IP: Flag) . No interaction between Nm23 and plakoglobin was detected in the soluble fraction. As plakoglobin expression (SCC9-P cells) increased the amount of Nm23 coprecipitated with N-cadherin (Figure 2a) , we examined the effects of deleting the N-terminal domain of plakoglobin on the association between Nm23 and N-cadherin. N-cadherin Figure 3 Nm23 interacts with a-catenin. (a) Soluble and insoluble fractions from SCC9 and SCC9-P cells were processed for sequential immunoprecipitation and immunoblotting using a-catenin and Nm23 antibodies, respectively. (b) Soluble and insoluble fractions from SCC9 and SCC9-P cells were processed for sequential immunoprecipitation and immunoblotting using Nm23, followed by N-cadherin, a-catenin and plakoglobin antibodies. (c) SCC9 and SCC9-P cells were formaldehyde fixed, CSK buffer extracted and processed for confocal microscopy using Nm23 (red) and a-catenin (green) antibodies. Nuclei were counterstained with DAPI (blue). Bar, 20 mm. A full colour version of this figure is available at the Oncogene journal online. 
Nm23-plakoglobin interaction is dependent on a-catenin
On showing that loss of the N-terminal domain of plakoglobin resulted in the loss of its association with Nm23-H1 and H2, we set out to determine whether acatenin was necessary for this interaction. To do so, we used PC3 cells, a prostate carcinoma cell line that is known to lack a-catenin while expressing E-cadherin, plakoglobin and Nm23 (Morton et al., 1993; Igawa et al., 1994; Daniel and Reynolds, 1995) . We first confirmed by western blot that PC3 cells lack a-catenin and express E-cadherin, plakoglobin and Nm23 (Figure 5a ). Next, we performed coimmunoprecipitation experiments using plakoglobin and a-catenin antibodies, and showed that Nm23-H1 and H2 were coprecipitated by neither of these antibodies in neither the soluble nor insoluble fractions (Figure 5b) . Furthermore, the supernatants from soluble and insoluble a-catenin and plakoglobin immunoprecipitates were processed for immunoblotting with Nm23. In these supernatants, Nm23-H1 and H2 were detected in the soluble but not the insoluble fractions. Reciprocal coimmunoprecipitation experiments confirmed our findings, showing that plakoglobin was not coprecipitated with Nm23-H1 and H2, but rather was present in the supernatants from both soluble and insoluble Nm23 immunoprecipitates (Figure 5c ).
To further confirm the coimmunoprecipitation study results, PC3 cells were processed for immunofluorescence with anti-Nm23-H1/H2, plakoglobin and a-catenin antibodies. Consistent with the lack of a-catenin expression, there was no detectable staining for this protein in these cells. Furthermore, in these cultures, Nm23-H1/H2 staining was detected throughout the cells but was notably absent from the peripheries (Figure 5d , Nm23/a-catenin). In contrast, plakoglobin's localization was primarily peripheral and membrane associated. Consistent with their distinct localizations, no detectable Nm23/plakoglobin codistribution was observed in these cells (Figure 5d , Nm23/Plakoglobin).
Nm23 interaction with plakoglobin, cadherin and a-catenin is not cell line specific To confirm that the interactions of Nm23 with the cadherin-catenin complex are not N-cadherin or cell line specific, we examined the associations of Nm23 with plakoglobin, a-catenin and E-cadherin in several nonepidermal cell lines. Soluble and insoluble fractions from the E-cadherin-and plakoglobin-expressing MCF-10-2A, MCF-7, SW620 and MDCK cells were processed for coimmunoprecipitation and confocal microscopy using plakoglobin, E-cadherin, a-catenin and Nm23 antibodies. Nm23-H1 and H2 coprecipitated with plakoglobin and a-catenin in both soluble and insoluble pools, whereas they were associated with E-cadherin only in the insoluble pool (Figure 6a ). Reciprocal coimmunoprecipitation using Nm23 antibodies further supported these results, in which plakoglobin, E-cadherin and a-catenin coprecipitated with Nm23-H1 and H2 from insoluble fractions of all cell lines (Figure 6b) . Immunofluorescence experiments also showed distinct colocalization between Nm23-H1/H2 and plakoglobin, E-cadherin and a-catenin in all cell lines (Figure 6c and Supplementary Figure 3) . These observations show that Nm23-H1 and H2 interact with both N-and E-cadherin and, furthermore, their associations with plakoglobin, a-catenin and cadherins are not cell specific.
Discussion
We identified Nm23 as a protein differentially expressed between plakoglobin-deficient SCC9 cells and their plakoglobin-expressing transfectants. Further analysis showed that plakoglobin expression led to the membrane localization of Nm23-H1/H2 and its interactions with plakoglobin, N-cadherin and a-catenin. Plakoglobin's interaction with Nm23-H1 and H2 required the first 123 amino acids in the N-terminal domain of plakoglobin, which mediates its interaction with acatenin, and furthermore, in cells lacking a-catenin, interactions between plakoglobin and Nm23-H1 and H2 were lost. Finally, we showed that the interactions between Nm23 and plakoglobin, cadherin and a-catenin are not cell line specific.
Our proteomic and microarray analyses identified several tumor suppressors, the levels of which were increased on expression of plakoglobin in SCC9 cells. We chose to focus on Nm23 for several reasons, the first of which being that, in a variety of different cancers, a decrease in both Nm23 and cadherin-mediated adhesion is observed, whereas the genes encoding these proteins remain unaltered (Chen et al., 2005; Che et al., 2006) . Previous studies have also shown that Nm23 is both targeted by and regulates c-myc, which was the first identified target of the Wnt/b-catenin signaling network (He et al., 1998; Schuldiner et al., 2002; Arnaud-Dabernat et al., 2004) . In addition, we recently showed that the levels and subcellular localization of Figure 5 a-Catenin is necessary for the interaction between plakoglobin and Nm23. (a) Thirty micrograms of total cellular proteins from PC3 and MCF-10-2A cells was resolved by SDS-PAGE and processed for immunoblotting with antibodies to a-catenin, plakoglobin, E-cadherin, Nm23 and actin. (b) Soluble and insoluble fractions from PC3 cell extracts were processed for immunoprecipitation using plakoglobin and a-catenin antibodies. The immune complexes, as well as the supernatants from the immunoprecipitations, were resolved by SDS-PAGE and blotted with Nm23 antibodies. TCL, total cell lysate. (c) Soluble and insoluble fractions from PC3 cell extracts were processed for immunoprecipitation using Nm23 antibodies. The immune complexes, as well as the supernatants from the immunoprecipitations, were resolved by SDS-PAGE and blotted with plakoglobin antibodies. TCL, total cell lysate. (d) PC3 cells were formaldehyde fixed, extracted with CSK buffer and processed for confocal microscopy using Nm23 (red) and a-catenin or plakoglobin (green) antibodies. Nuclei were counterstained with DAPI (blue). Bar, 20 mm. A full colour version of this figure is available at the Oncogene journal online.
plakoglobin can modulate the amount of b-catenin and its signaling function in a cell context-dependent manner (Li et al., 2007) .
Our results lend support to the observation made during our proteomic studies, which identified Nm23-H2 as being increased nearly fivefold in SCC9-P cells as compared with parental SCC9 cells. Western blot analysis revealed that, although the levels of both Nm23-H1 and H2 were significantly increased on plakoglobin expression, the levels of Nm23-H2 were more notably increased. Examination of the effect of plakoglobin expression on the amount of Nm23-H1 and H2 mRNA by RT-PCR showed increased levels of Nm23-H1 mRNA only, consistent with the microarray analysis, which revealed significantly increased Nm23-H1 but not H2 expression in SCC9-P cells. These results together suggest that plakoglobin may regulate Nm23-H1 at the level of transcription, and increases the levels of Nm23-H2 protein. Plakoglobin may increase Nm23-H2 protein levels by increasing its stability through their interactions, by inhibiting Nm23-H2's degradation, or by other posttranslational mechanisms. In addition, the higher levels of Nm23-H1 transcripts that resulted in increased protein levels (although not as notable as Nm23-H2) could promote interactions between Nm23-H1 and H2, resulting in its increased stability. Whether plakoglobin acts directly as a transcriptional regulator of Nm23-H1 expression or alters the activity of other transcription factors, and why it regulates Nm23-H1 gene expression and H2 protein levels, remains unknown and is under investigation.
We observed Nm23-H1/H2 at the membrane in SCC9-P cells, which was concurrent with a mesenchymal-epidermoid transition and the formation of stable junctional complexes, and decided to further investigate whether Nm23-H1/H2 localized to junctional complexes, taking into account previous studies describing its membrane localization (Palacios et al., 2002; Che et al., 2006) . Immunofluorescence analysis revealed that Nm23-H1/H2 colocalized with the total and the cytoskeleton-associated pool of plakoglobin and N-cadherin in SCC9-P cells.
Reciprocal coimmunoprecipitation studies corroborated our immunofluorescence results and, further, allowed us to distinguish between Nm23-H1 and H2, and their respective interactions with the junctional components, which could not be differentiated by microscopy because the immunofluorescence antibodies recognized both Nm23-H1 and H2. More specifically, greater amounts of Nm23-H2 coprecipitated with plakoglobin in insoluble fractions than did Nm23-H1, whereas only Nm23-H2 coprecipitated with plakoglobin in the soluble fraction of these cells, suggesting that Nm23-H2-plakoglobin interactions may not require or precede Nm23-H1 associations. Whereas Nm23-H1 and (primarily) H2 also interacted with both pools of N-cadherin in SCC9-P cells, these interactions were significantly increased in the insoluble pool. That Nm23 Figure 6 Nm23 interacts with plakoglobin, E-cadherin and a-catenin in various epithelial cell lines. (a) Soluble and insoluble fractions from MCF-10-2A, MCF-7, MDCK and SW620 cell extracts were processed for immunoprecipitation using plakoglobin, E-cadherin and a-catenin antibodies. The immune complexes were resolved by SDS-PAGE and blotted with Nm23 antibodies. (b) Soluble and insoluble fractions from MCF-10-2A, MCF-7, MDCK and SW620 cell extracts were processed for immunoprecipitation using Nm23 antibodies. The immune complexes were resolved by SDS-PAGE and blotted with E-cadherin, a-catenin and plakoglobin antibodies. (c) MCF-10-2A, MCF-7, MDCK and SW620 cells were CSK buffer extracted, formaldehyde fixed, and processed for confocal microscopy using Nm23 (red) and plakoglobin, E-cadherin or a-catenin (green) antibodies. Nuclei were counterstained with DAPI (blue). Bar, 20 mm. A full colour version of this figure is available at the Oncogene journal online.
Plakoglobin interacts with and regulates Nm23
Z Aktary et al interacted with plakoglobin and N-cadherin, and primarily in the cytoskeleton-associated pool of proteins, suggested that plakoglobin may have a role in recruiting Nm23-H2 and, to a lesser extent, Nm23-H1, to the cadherin-catenin complex at the adherens junction. As, at this junction, a-catenin mediates the link between the cadherin-catenin complex and the actin cytoskeleton, we sought to determine whether Nm23-H1/H2 and a-catenin interact. We found that they do interact, that the primary interaction was between Nm23-H2 and a-catenin, and that these interactions are independent of plakoglobin. Furthermore, we identified the N-terminal domain of plakoglobin, which is essential for its interaction with a-catenin (Sacco et al., 1995) , as being necessary for its interaction with Nm23. Recent studies have shown the existence of two distinct cellular pools of a-catenin: one, composed of a-catenin monomers, which associate with the b-catenin-E-cadherin complex at the membrane, and another, composed of a-catenin dimers, which associate with the actin cytoskeleton Yamada et al., 2005) . These distinct pools of a-catenin may help to explain why so much more Nm23-H2 is associated with the junctional components in the cytoskeleton-associated pool: it may be possible that one pool of a-catenin associates with both Nm23-H1 and H2, whereas the other pool associates primarily with Nm23-H2.
Coimmunoprecipitation experiments in the a-catenindeficient PC3 cell line were performed to further characterize the role that a-catenin has in mediating the interactions between plakoglobin and Nm23-H1 and H2. The results of these experiments confirmed that a-catenin is a critical component of the plakoglobinNm23-H1/H2 complex, as Nm23-H1 and H2 did not coprecipitate with plakoglobin antibodies in these cells. Furthermore, all Nm23 in PC3 cells were detected in the immunoprecipitate supernatants from the soluble fractions only. Consistent with these results, Nm23-H1 and H2 were found in total cell extracts from the soluble fraction of PC3 cells, but not from the insoluble fraction. These findings suggest that in cells that lack a-catenin, Nm23-H1 and H2 do not interact with any junctional components that are cytoskeleton associated, and as a result remain exclusively in soluble fractions. Reciprocal coimmunoprecipitation experiments using Nm23 antibodies further confirmed the absence of plakoglobin in Nm23 immunoprecipitates. In these cells, plakoglobin was detected in the immunoprecipitate supernatants after Nm23 was removed. The fact that Nm23-H1/H2 and plakoglobin were not associated in PC3 cells was also detected by confocal microscopy, which clearly showed the absence of their membrane codistribution in these cells. Finally, examination of additional cell lines expressing E-cadherin showed that Nm23-H1 and H2 interact with both N-and E-cadherin and its associations with cadherins and plakoglobin are neither tissue nor species specific.
Plakoglobin has often been associated with tumorsuppressor activity, although the mechanisms behind this activity remain unclear (Simcha et al., 1996; Pantel et al., 1998; Parker et al., 1998; Winn et al., 2002; Reiger-Christ et al., 2005) . More recently, downregulation of plakoglobin was also shown to increase the risk of pulmonary metastasis in soft tissue sarcomas (Kanazawa et al., 2008) and was associated with poor differentiation of oral squamous cell carcinoma and with lymph node metastases (Narkio-Makela et al., 2009) , further supporting the idea that plakoglobin functions to suppress metastasis in addition to tumor formation. Similarly, a number of studies have shown that in addition to its well-documented role as a metastasis suppressor, Nm23-H1 and H2 have growth inhibitory activities (Jin et al., 2009; Lee et al., 2009) . Our results suggest that plakoglobin's tumor/metastasissuppressor activity may be mediated through the modulation of the levels, stability and subcellular localization of Nm23. In particular, plakoglobin, at least in the context of squamous cell oral carcinomas, exerts its effects more notably on Nm23-H2. This result is supported by a previous study, which found that Nm23-H2 has a critical role as a metastasis/tumor suppressor in oral carcinomas (Miyazaki et al., 1999) . Collectively, these observations suggest that plakoglobin and Nm23 may exert (at least part of) their antitumor/ metastasis activities in conjunction with one another. To this point, no studies have been performed that have examined the (lack of) expression of both Nm23 and plakoglobin in tumors.
In conclusion, although the exact roles that Nm23 has in tumorigenesis and metastasis remain unclear, our results and those of others indicate that it is the interactions of Nm23 with other cellular proteins that determine what type of a role it has in these processes (Kim et al., 2009) . Here, we identified plakoglobin as a novel Nm23 interacting partner, an observation that also provides a potential mechanism for the oftensuggested role of plakoglobin as a tumor suppressor. The larger implication of this novel observation is the role of plakoglobin as a potential modulator of growthregulating proteins, the expressions of which are compromised or altered during tumor progression and metastasis.
Materials and methods

Cell culture and conditions
All tissue culture reagents were purchased from Invitrogen (Burlington, Ontario, Canada) unless stated otherwise. The human tongue squamous cell carcinoma cell line SCC9, plakoglobin-expressing SCC9, MDCK, MCF-7, MCF-10-2A and PC3 cells have been described previously (Pasdar and Nelson, 1988a; Torlakovic et al., 2002; Li et al., 2007; Lam et al., 2009) . The colon carcinoma cell line SW620 was obtained from the American Type Culture Collection (ATCC, Manassas, VA, USA), and was maintained in Leibovitz's L-15 medium supplemented with 2 mM L-glutamine, 10% FBS and 1% antibiotics.
Antibodies
A list of antibodies, fluorescent probes and their respective dilutions in specific assays is presented in Table 1 .
RNA isolation and RT-PCR
All chemicals and reagents were purchased from SigmaAldrich (Oakville, Ontario, Canada) unless stated otherwise. RNA was isolated from 150 mm confluent cultures using the RNeasy Plus Mini Kit (Qiagen, Valencia, CA, USA) according to the manufacturer's protocol. Following isolation, RNA was pretreated with RNase-free DNase I and subsequently used for reverse transcription using the RevertAid H Minus First Strand cDNA Synthesis Kit (Fermentas, Burlington, Ontario, Canada). Polymerase chain reaction was then performed (PuReTaq Ready-to-go PCR beads) on the amplified cDNA. Primer sequences are outlined in Table 2 . RT-PCR products were resolved on 2% agarose gels and visualized by ethidium bromide staining.
Preparation of total cell extracts and western blotting Cells were grown to confluence in 100 mm dishes, washed twice with cold PBS, solubilized in hot SDS sample buffer (10 mM Tris-HCl pH 6.8, 2% (w/v) SDS, 50 mM dithiothreitol, 2 mM EDTA, 0.5 mM PMSF) and boiled for 10 min. Protein determination was performed using Bradford (Pierce, Nepean, Ontario, Canada) assays according to the manufacturer's instructions. Twenty-five micrograms of total cellular protein were resolved by SDS-PAGE, transferred to nitrocellulose membranes (Biorad, Mississauga, Ontario, Canada), processed for immunoblotting and developed by standard ECL (Perkin Elmer LAS) procedures.
Immunofluorescence analysis
Confluent cultures of cells grown on glass coverslips were rinsed twice with cold PBS, extracted with cytoskeleton extraction (CSK, Pasdar and Nelson, 1988b) buffer (50 mM NaCl, 300 mM Sucrose, 10 mM PIPES pH 6.8, 3 mM MgCl 2 , 0.5% Triton X-100, 1.2 mM PMSF, and 1 mg/ml DNase and RNase) for 10 min and fixed on ice with 1.75% formaldehyde for 15 min. Alternatively, cells were fixed with formaldehyde first and then permeabilized with CSK buffer. Coverslips were blocked for 1 h with 4.0% goat serum and 50 mM NH 4 Cl 4 in PBS containing 0.2% BSA (PBS-BSA) and processed for indirect immunofluorescence. Primary antibody incubation for 1 hr at room temperature was followed by 20 min incubation with fluorochrome-conjugated species-specific secondary antibodies. All antibodies were diluted in PBS-BSA. Nuclei were counterstained for 5 min with DAPI (1:2000 in PBS). Coverslips were mounted in elvanol containing 0.2% (w/v) paraphenylene diamine and viewed using a Â 63 objective For all primers, pre-denaturation was done at 95 1C for 5 min. This was followed by 35 cycles of denaturation at 95 1C for 30 s, annealing, and extension at 72 1C for 45 s.
Plakoglobin interacts with and regulates Nm23 Z Aktary et al of an LSM510 META (Zeiss) laser scanning confocal microscope.
Immunoprecipitation
The following procedures were carried out at 4 1C. Confluent cultures (100 mm) were washed twice with cold PBS containing 1 mM Ca 2 þ and extracted for 20 min with a modified cytoskeleton extraction buffer (Pasdar and Nelson, 1988a;  10 mM PIPES pH 6.8, 100 mM NaCl, 300 mM sucrose, 3 mM MgCl 2 , 0.5% NP-40, 1 mM NaF, 1 mM Na 3 VO 4 and protease inhibitor cocktail). Cells were removed from the plates and centrifuged at 20 000 r.p.m. for 10 min. The resulting supernatant (soluble fraction) was separated from the pellet (insoluble), which was solubilized in SDS immunoprecipitation buffer (1% SDS, 10 mM Tris-HCl pH 7.5, 2 mM EDTA, 0.5 mM DTT and PMSF) and boiled for 15 min. The SDS was diluted to 0.1% with immunoprecipitation buffer. All extracts were divided into equal aliquots for immunoprecipitation. Antibodies and 50 ml protein A Sepharose CL-4B beads (Pierce) were added to the extracts, which were then incubated overnight on a rocker rotator at 4 1C. To ensure complete depletion, samples were centrifuged briefly and the resulting supernatants were processed for immunoprecipitation for 3 h. Beads from the two rounds of immunoprecipitations were combined, washed three times with immunoprecipitation buffer and immune complexes were separated by solubilization in 100 ml SDS sample buffer (10 mM Tris-HCl pH 6.8, 2% (w/v) SDS, 2 mM EDTA, 0.5 mM PMSF, 100 mM dithiothreitol, 0.1% bromophenol blue). Equivalent amounts of immunoprecipitated proteins were loaded onto SDS polyacrylamide gels and processed for western blot as described above.
